https://www.formula30a.com/research-articles/neuroprotective-and-blood-retinal-barrier-preserving-effects-of-cannabidiol-in-experimental-diabetes 2022-08-08 https://www.formula30a.com/research-articles/a-single-dose-of-cannabidiol-reduces-blood-pressure-in-healthy-volunteers-in-a-randomized-crossover-study 2022-08-04 https://www.formula30a.com/research-articles/efficacy-and-safety-of-cannabidiol-and-tetrahydrocannabivarin-on-glycemic-and-lipid-parameters-in-patients-with-type-2-diabetes%3A-a-randomized%2C-double-blind%2C-placebo-controlled%2C-parallel-group-pilot-study 2022-08-04 https://www.formula30a.com/research-articles/neuroprotective-and-blood-retinal-barrier-preserving-effects-of-cannabidiol-in-experimental-diabetes 2022-08-04 https://www.formula30a.com/research-articles/in-vivo-evidence-for-therapeutic-properties-of-cannabidiol-(cbd)-for-alzheimer's-disease 2022-08-04 https://www.formula30a.com/research-articles/potential-and-limits-of-cannabinoids-in-alzheimer%E2%80%99s-disease-therapy 2022-08-04 https://www.formula30a.com/research-articles/prescription-of-a-thc%2Fcbd-based-medication-to-patients-with-dementia%3A-a-pilot-study-in-geneva 2022-08-04 https://www.formula30a.com/research-articles/amyloid-proteotoxicity-initiates-an-inflammatory-response-blocked-by-cannabinoids 2022-08-04